elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q43254054-3C016092-1A9E-45A6-9576-6512F5C4A099
Q43254054-3C016092-1A9E-45A6-9576-6512F5C4A099
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43254054-3C016092-1A9E-45A6-9576-6512F5C4A099
Weekly treatment with a combination of bortezomib and bendamustine in relapsed or refractory indolent non-Hodgkin lymphoma.
P2860
Q43254054-3C016092-1A9E-45A6-9576-6512F5C4A099
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43254054-3C016092-1A9E-45A6-9576-6512F5C4A099
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
46825f2f3744a0546e9ee0608464ab6c4e7f2cfb
P2860
Fludarabine and bendamustine in refractory and relapsed indolent lymphoma--a multicenter phase I/II Trial of the east german society of hematology and oncology (OSHO).